美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
50090-6062-1	50090-6062	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide	Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20220829	N/A	ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 10 mg/1	90 TABLET in 1 BOTTLE (50090-6062-1)
50090-6062-2	50090-6062	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide	Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20230317	N/A	ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 10 mg/1	100 TABLET in 1 BOTTLE (50090-6062-2)
50090-6062-0	50090-6062	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide	Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20220829	N/A	ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 10 mg/1	30 TABLET in 1 BOTTLE (50090-6062-0)
50090-6204-1	50090-6204	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide	Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20221104	N/A	ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 20 mg/1	90 TABLET in 1 BOTTLE (50090-6204-1)
50090-6204-2	50090-6204	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide	Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20230309	N/A	ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 20 mg/1	100 TABLET in 1 BOTTLE (50090-6204-2)
50090-6204-0	50090-6204	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide	Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20221104	N/A	ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 20 mg/1	30 TABLET in 1 BOTTLE (50090-6204-0)